224 related articles for article (PubMed ID: 18443367)
1. Comment on: DiChiara et al. (2007) The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study: Diabetes 56:3014-3019, 2007.
Klein PS
Diabetes; 2008 May; 57(5):e10; author reply e11. PubMed ID: 18443367
[No Abstract] [Full Text] [Related]
2. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of aspirin resistance in patients with type 2 diabetes.
Fateh-Moghadam S; Plöckinger U; Cabeza N; Htun P; Reuter T; Ersel S; Gawaz M; Dietz R; Bocksch W
Acta Diabetol; 2005 Jun; 42(2):99-103. PubMed ID: 15944844
[TBL] [Abstract][Full Text] [Related]
4. [Hyperbaric oxygenation and antiaggregants: effects on platelet function in patients with ischemic heart disease].
Seriakov VV; Feofanova ID
Anesteziol Reanimatol; 1997; (2):31-3. PubMed ID: 9221683
[TBL] [Abstract][Full Text] [Related]
5. Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update.
Di Minno MN; Lupoli R; Palmieri NM; Russolillo A; Buonauro A; Di Minno G
Thromb Res; 2012 Mar; 129(3):341-4. PubMed ID: 22142668
[TBL] [Abstract][Full Text] [Related]
6. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
[TBL] [Abstract][Full Text] [Related]
7. Effect of naftidrofuryl on platelet aggregation in plasma from aspirin treated patients: an in vitro study.
Le Dévéhat C; Khodabandehlou T; Mosnier M
Clin Hemorheol Microcirc; 2000; 22(3):197-204. PubMed ID: 10976713
[TBL] [Abstract][Full Text] [Related]
8. Letter by Violi et al regarding article, "Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization".
Violi F; Pignatelli P; Basili S
Circulation; 2010 Aug; 122(7):e429; author reply e430. PubMed ID: 20713906
[No Abstract] [Full Text] [Related]
9. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
[TBL] [Abstract][Full Text] [Related]
10. Aspirin resistance and diabetes mellitus.
Ajjan R; Storey RF; Grant PJ
Diabetologia; 2008 Mar; 51(3):385-90. PubMed ID: 18197397
[No Abstract] [Full Text] [Related]
11. Platelet activity and outcome after intracerebral hemorrhage.
Naidech AM; Bernstein RA; Levasseur K; Bassin SL; Bendok BR; Batjer HH; Bleck TP; Alberts MJ
Ann Neurol; 2009 Mar; 65(3):352-6. PubMed ID: 19334079
[TBL] [Abstract][Full Text] [Related]
12. Aspirin in type 2 diabetes: is there any evidence base?
Walsh M; Spurling G
BMJ; 2008 Oct; 337():a1902. PubMed ID: 18927174
[No Abstract] [Full Text] [Related]
13. Further ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes.
Bliden KP; Tantry US; DiChiara J; Gurbel PA
Circ Cardiovasc Interv; 2011 Apr; 4(2):118-20. PubMed ID: 21505165
[No Abstract] [Full Text] [Related]
14. Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets.
O'Kane PD; Reebye V; Ji Y; Stratton P; Jackson G; Ferro A
J Mol Cell Cardiol; 2008 Aug; 45(2):223-9. PubMed ID: 18606420
[TBL] [Abstract][Full Text] [Related]
15. Picotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?
Gresele P; Migliacci R
Eur Heart J; 2004 Oct; 25(20):1769-71. PubMed ID: 15474690
[No Abstract] [Full Text] [Related]
16. Aspirin resistance after coronary artery bypass grafting.
Zimmermann N; Kienzle P; Weber AA; Winter J; Gams E; Schrör K; Hohlfeld T
J Thorac Cardiovasc Surg; 2001 May; 121(5):982-4. PubMed ID: 11326244
[No Abstract] [Full Text] [Related]
17. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
Lepäntalo A; Virtanen KS; Reséndiz JC; Mikkelsson J; Viiri LE; Karhunen PJ; Lassila R
Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
[TBL] [Abstract][Full Text] [Related]
18. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
[TBL] [Abstract][Full Text] [Related]
19. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
Wienbergen H; Senges J; Gitt AK
Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
[No Abstract] [Full Text] [Related]
20. A study of aspirin resistance in type 2 diabetes.
Singla MK; Lahiri P; Mukhopadhyay P; Pandit K; Chaudhuri U; Chowdhury S
J Indian Med Assoc; 2008 Nov; 106(11):720, 722-3, 740. PubMed ID: 19368097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
